3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
23
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Melanoma
12
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
4
Lung Neoplasms
4
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Recurrent Squamous Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Motor Activity
1
Kidney Neoplasms
1
Carcinoma, Renal Cell
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Surveys and Questionnaires
15
Radiosurgery
14
Magnetic Resonance Imaging
11
Magnetic Resonance Spectroscopy
10
Neuropsychological Tests
8
Radiotherapy
7
Radiation
4
Blood Specimen Collection
4
Patient Reported Outcome Measures
3
sacituzumab govitecan
2
Trastuzumab
2
Surgical Procedures, Operative
2
Quality of Life
2
Physical Examination
2
Phlebotomy
2
Perfusion Magnetic Resonance Imaging
2
Lead
2
Lapatinib
2
Interviews as Topic
2
Immunotherapy
2
Drug Therapy
2
Data Collection
2
Brain Mapping
2
Bevacizumab
2
Amplified Fragment Length Polymorphism Analysis
2
Aminolevulinic Acid
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Brain Neoplasms
×
Ipilimumab
×
Clear all
NCT03458455
2023-11-01
TREATMENT
Oslo University Hospital
Unknown
200 enrolled